LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.

    Zoller, Emily / Valente, Connie / Baker, Kyle / Klepser, Michael E

    Drug design, development and therapy

    2010  Volume 4, Page(s) 299–311

    Abstract: ... of fungal pathogens, including yeasts and moulds. Clinical data have demonstrated the clinical utility ... of posaconazole against many therapy-refractory pathogens, including Aspergillus spp, Fusarium spp, and ... for the prophylaxis and management of various fungal infections among high-risk patients. ...

    Abstract Posaconazole is an extended-spectrum azole antifungal that exhibits activity against a broad range of fungal pathogens, including yeasts and moulds. Clinical data have demonstrated the clinical utility of posaconazole against many therapy-refractory pathogens, including Aspergillus spp, Fusarium spp, and Zygomycetes. These data have provided clinicians with hope in these difficult situations. Some of the limitations that have emerged with the use of posaconazole are the lack of an intravenous formulation and erratic drug absorption. This fact is further complicated by the existence of saturable posaconazole absorption. Despite these drawbacks, posaconazole appears poised to become a prominent therapeutic modality for the prophylaxis and management of various fungal infections among high-risk patients.
    MeSH term(s) Animals ; Antifungal Agents/administration & dosage ; Antifungal Agents/pharmacokinetics ; Antifungal Agents/therapeutic use ; Drug Resistance, Fungal ; Fungi/drug effects ; Humans ; Mycoses/drug therapy ; Mycoses/microbiology ; Mycoses/prevention & control ; Risk Factors ; Triazoles/administration & dosage ; Triazoles/pharmacokinetics ; Triazoles/therapeutic use
    Chemical Substances Antifungal Agents ; Triazoles ; posaconazole (6TK1G07BHZ)
    Language English
    Publishing date 2010-11-04
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2451346-5
    ISSN 1177-8881 ; 1177-8881
    ISSN (online) 1177-8881
    ISSN 1177-8881
    DOI 10.2147/DDDT.S7773
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections

    Emily Zoller / Connie Valente / Kyle Baker

    Drug Design, Development and Therapy, Vol 2010, Iss default, Pp 299-

    2010  Volume 311

    Abstract: ... have demonstrated the clinical utility of posaconazole against many therapy-refractory pathogens ... that exhibits activity against a broad range of fungal pathogens, including yeasts and moulds. Clinical data ... a prominent therapeutic modality for the prophylaxis and management of various fungal infections among high ...

    Abstract Emily Zoller, Connie Valente, Kyle Baker, Michael E KlepserFerris State University College of Pharmacy, Kalamazoo, Michigan, USAAbstract: Posaconazole is an extended-spectrum azole antifungal that exhibits activity against a broad range of fungal pathogens, including yeasts and moulds. Clinical data have demonstrated the clinical utility of posaconazole against many therapy-refractory pathogens, including Aspergillus spp, Fusarium spp, and Zygomycetes. These data have provided clinicians with hope in these difficult situations. Some of the limitations that have emerged with the use of posaconazole are the lack of an intravenous formulation and erratic drug absorption. This fact is further complicated by the existence of saturable posaconazole absorption. Despite these drawbacks, posaconazole appears poised to become a prominent therapeutic modality for the prophylaxis and management of various fungal infections among high-risk patients.Keywords: posaconazole, pharmacokinetics, fungal infections
    Keywords Medicine (General) ; R5-920 ; Medicine ; R ; DOAJ:Medicine (General) ; DOAJ:Health Sciences ; Therapeutics. Pharmacology ; RM1-950 ; DOAJ:Therapeutics
    Subject code 610
    Language English
    Publishing date 2010-11-01T00:00:00Z
    Publisher Dove Medical Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top